Xiromerisiou G - Search Results

1

Large-scale replication and heterogeneity in Parkinson disease genetic loci.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C, Bertram L, Bozi M, Crosiers D, Clarke C, Facheris M, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon B, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEO-PD Consortium. Sharma M, et al. Among authors: xiromerisiou g. Neurology. 2012 Aug 14;79(7):659-67. doi: 10.1212/WNL.0b013e318264e353. Epub 2012 Jul 11. Neurology. 2012. PMID: 22786590 Free PMC article.

2

Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up.

Xiromerisiou G, Lampropoulos IC, Dermitzakis EV, Vikelis M, Marogianni C, Mysiris D, Argyriou AA. Xiromerisiou G, et al. Toxins (Basel). 2023 Aug 31;15(9):539. doi: 10.3390/toxins15090539. Toxins (Basel). 2023. PMID: 37755965 Free PMC article.

3

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Vikelis M, Dermitzakis EV, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Rikos D, Argyriou AA. Vikelis M, et al. Among authors: xiromerisiou g. J Clin Med. 2023 Jul 6;12(13):4526. doi: 10.3390/jcm12134526. J Clin Med. 2023. PMID: 37445560 Free PMC article.

4

The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases.

Sintila SA, Boziki M, Bakirtzis C, Stardeli T, Smyrni N, Nikolaidis I, Parissis D, Afrantou T, Karapanayiotides T, Koutroulou I, Giantzi V, Theotokis P, Kesidou E, Xiromerisiou G, Dardiotis E, Ioannidis P, Grigoriadis N. Sintila SA, et al. Among authors: xiromerisiou g. Medicina (Kaunas). 2023 Jan 30;59(2):266. doi: 10.3390/medicina59020266. Medicina (Kaunas). 2023. PMID: 36837468 Free PMC article.

5

Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Argyriou AA, Dermitzakis EV, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Vikelis M. Argyriou AA, et al. Among authors: xiromerisiou g. J Clin Med. 2023 Apr 29;12(9):3218. doi: 10.3390/jcm12093218. J Clin Med. 2023. PMID: 37176658 Free PMC article.

6

Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.

Clarimon J, Xiromerisiou G, Eerola J, Gourbali V, Hellström O, Dardiotis E, Peuralinna T, Papadimitriou A, Hadjigeorgiou GM, Tienari PJ, Singleton AB. Clarimon J, et al. Among authors: xiromerisiou g. BMC Neurol. 2005 Jun 20;5:11. doi: 10.1186/1471-2377-5-11. BMC Neurol. 2005. PMID: 15967032 Free PMC article.

7

IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury.

Hadjigeorgiou GM, Paterakis K, Dardiotis E, Dardioti M, Aggelakis K, Tasiou A, Xiromerisiou G, Komnos A, Zintzaras E, Scarmeas N, Papadimitriou A, Karantanas A. Hadjigeorgiou GM, et al. Among authors: xiromerisiou g. Neurology. 2005 Oct 11;65(7):1077-82. doi: 10.1212/01.wnl.0000178890.93795.0e. Neurology. 2005. PMID: 16217062

8

Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.

Hadjigeorgiou GM, Xiromerisiou G, Gourbali V, Aggelakis K, Scarmeas N, Papadimitriou A, Singleton A. Hadjigeorgiou GM, et al. Among authors: xiromerisiou g. Mov Disord. 2006 Apr;21(4):534-9. doi: 10.1002/mds.20752. Mov Disord. 2006. PMID: 16250025

9

The human prion gene M129V polymorphism is not associated with idiopathic Parkinson's disease in three distinct populations.

Scholz SW, Xiromerisiou G, Fung HC, Eerola J, Hellström O, Papadimitriou A, Hadjigeorgiou GM, Tienari PJ, Fernandez HH, Mandel R, Okun MS, Gwinn-Hardy K, Singleton AB. Scholz SW, et al. Among authors: xiromerisiou g. Neurosci Lett. 2006 Mar 13;395(3):227-9. doi: 10.1016/j.neulet.2005.10.081. Epub 2005 Nov 18. Neurosci Lett. 2006. PMID: 16298483

10

Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium.

Paisán-Ruíz C, Evans EW, Jain S, Xiromerisiou G, Gibbs JR, Eerola J, Gourbali V, Hellström O, Duckworth J, Papadimitriou A, Tienari PJ, Hadjigeorgiou GM, Singleton AB. Paisán-Ruíz C, et al. Among authors: xiromerisiou g. J Med Genet. 2006 Feb;43(2):e9. doi: 10.1136/jmg.2005.036889. J Med Genet. 2006. PMID: 16467219 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page